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Antibodies Up on Top
Although T-cell-mediated events 
are critical for the pathogenesis 
of psoriasis, historical data have 
indicated that immunoglobulin G 
(IgG) and complement are 
deposited in the upper epidermis 
and stratum corneum of lesions. 
El-Rachkidy and colleagues 
recently identified IgG-reactive 
autoantigens in the stratum 
corneum, including homologues 
of the serpin, squamous cell 
carcinoma antigen. Interestingly, 
healthy control subjects also 
exhibited detectable levels of 
these antibodies, raising the 
possibility that these antibody–
antigen interactions are an early 
event in psoriasis following the 
alteration of local homeostasis. 
Additionally, these results suggest 
that blockade of complement may 
be a viable therapeutic alternative 
for psoriasis. See page 2219
Keratinocyte 
Reactivity
Patients with severe atopic 
dermatitis (AD) exhibit 
autoreactive IgE, suggesting that 
autoimmunity is a pathogenic 
factor in this disease. Although 
several human autoallergens have 
been identified from an epithelial 
carcinoma cell line, Altrichter 
and colleagues discovered that 
additional proteins from primary 
keratinocytes were reactive with 
IgE in the sera of AD patients. This 
autoreactivity was significantly 
correlated with disease severity, 
implicating these autoantibodies 
in the pathophysiology of AD. 
Furthermore, keratinocyte surface 
molecules were IgE-reactive 
target molecules. Together, these 
data highlight a patient subgroup 
that may benefit from anti-IgE 
treatment. See page 2232
It’s All in the Photos
The psoriasis area severity index was devel-
oped to quantify and standardize evalu-
ation of psoriasis between baseline and 
posttreatment states; however, the validity 
and reproducibility of this index have been 
challenged. Farhi and colleagues exam-
ined the global assessment of severity and 
change via standardized photographs. This 
method was shown to be accurate and con-
sistent with as few as five expert examiners. 
In addition, excellent agreement was noted 
between the clinical assessment and the overall panel photographic assessment. The 
use of photography for daily practice and clinical research is advantageous because it 
improves communicability, transparency, blind assessment, independence of assess-
ments, and homogeneity in multicenter trials. See page 2198
Improving Attachment
Recessive dystrophic epidermolysis bullosa 
(RDEB) is caused by loss-of-function muta-
tions in type VII collagen, the major com-
ponent of anchoring fibrils that secure the 
epidermis to the underlying dermis. Animal 
models have supported intradermal fibro-
blast injections to generate new type VII 
collagen and anchoring fibrils. Wong and 
colleagues demonstrated that intradermal 
injection of cultured allogeneic dermal fibroblasts into RDEB patients resulted in a 
sustained increase in type VII collagen at the dermal–epidermal junction, as well as 
improvement in dermal–epidermal adhesion. Despite this improvement, the increased 
collagen and resultant anchoring fibrils appeared to be mostly mutant. Future inves-
tigations into collagen or biosynthetic gel delivery of fibroblasts to RDEB wounds are 
warranted. See page 2179
Drug Delivery by Depilatory
Although the stratum corneum limits transcutaneous 
penetration of external molecules, pharmacologic 
manipulation of this barrier for drug delivery has 
been investigated because this route offers easy 
access, better patient compliance, and avoidance 
of the complications associated with parenteral 
delivery. Lee and colleagues demonstrated that 
the depilatory cream thioglycolate enhanced 
transepidermal penetration of both hydrophilic 
and hydrophobic drugs. Both the intracellular 
integrity and the intercellular lipids of corneocytes 
were disrupted by this depilatory agent. Understanding this mechanism may allow 
development of effective strategies for the percutaneous delivery of drugs, macro-
molecules, and nanoparticles. See page 2240
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